EUVIMEDEUVIMED entdecken
MetaanalyseVergleichsstudieÜbersichtsarbeitOpen Access · CC BY 4.0

Vaginal misoprostol versus vaginal dinoprostone for cervical ripening and induction of labour: An individual participant data meta‐analysis of randomised controlled trials

Malitha Patabendige iD, Fei Chan, Christophe Vayssiere, Virginie Ehlinger, Nicolette Van Gemund, Saskia le Cessie, Martina Prager, Lena Marions, Patrick Rozenberg, Sylvie Chevret, David C Young, Paul A Le Roux und 5 weitere

BJOG: An International Journal of Obstetrics & Gynaecology · 2024

DOI: 10.1111/1471-0528.17794 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift BJOG: An International Journal of Obstetrics & Gynaecology, 2024. Verfasst von Malitha Patabendige und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynaecology, Monash Medical Centre, Monash University, Clayton, Victoria, Australia. Hauptthemen laut MEDLINE: Labor, Induced, Misoprostol, Dinoprostone, Oxytocics. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, Australian Government, National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Induction of labour (IOL) is common practice and different methods carry different effectiveness and safety profiles.

Objectives

To compare the effectiveness, and maternal and perinatal safety outcomes of IOL with vaginal misoprostol versus vaginal dinoprostone using individual participant data from randomised clinical trials. Search strategy The following databases were searched from inception to March 2023: CINAHL Plus, ClinicalTrials.gov, Cochrane Pregnancy and Childbirth Group Trial Register, Ovid Embase, Ovid Emcare, Ovid MEDLINE, Scopus and the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP). Selection criteria Randomised controlled trials (RCTs), with viable singleton gestation, no language restrictions, and all published and unpublished data. Data collection and analysis An individual participant data meta‐analysis was carried out. Main results Ten of 52 eligible trials provided individual participant data, of which two were excluded after checking data integrity. The remaining eight trials compared low‐dose vaginal misoprostol versus dinoprostone, including 4180 women undergoing IOL, which represents 32.8% of all participants in the published RCTs. Of these, 2077 were assigned to low‐dose vaginal misoprostol and 2103 were assigned to vaginal dinoprostone. Compared with vaginal dinoprostone, low‐dose vaginal misoprostol had a comparable rate of vaginal birth. Composite adverse perinatal outcomes did not differ between the groups. Compared with vaginal dinoprostone, composite adverse maternal outcomes were significantly lower with low‐dose vaginal misoprostol (aOR 0.80, 95% CI 0.65–0.98, P = 0.03, I 2 = 0%).

Conclusions

Low‐dose vaginal misoprostol and vaginal dinoprostone for IOL are comparable in terms of effectiveness and perinatal safety. However, low‐dose vaginal misoprostol is likely to lead to a lower rate of composite adverse maternal outcomes than vaginal dinoprostone.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Labor, InducedMisoprostolDinoprostoneOxytocicsRandomized Controlled Trials as TopicCervical RipeningHumansFemalePregnancyAdministration, Intravaginal

Stichwörter der Autor:innen

IPDdinoprostoneindividual participant datainduction of labourmeta‐analysismisoprostolprostaglandinrandomised trials

Substanzen

MisoprostolDinoprostoneOxytocics

Autor:innen und Institutionen

  • Department of Obstetrics and Gynaecology, Monash Medical Centre, Monash University, Clayton, Victoria, Australia.
  • Ministry of Health, Colombo, Sri Lanka.
  • Monash Health - Casey Hospital, Berwick, Victoria, Australia.
  • Centre for Epidemiology and Research in Population Health (CERPOP), UMR1295, Toulouse University, Inserm, Paul Sabatier University, Toulouse, France.
  • Department of Obstetrics and Gynaecology, Paule de Viguier Hospital, Toulouse University Hospital, Toulouse, France.
  • Department of Obstetrics and Gynaecology, Franciscus Gasthuis, Rotterdam, the Netherlands.

ORCID-Profile: Malitha Patabendige, Daniel L Rolnik, Ben W Mol, Wentao Li

Förderung

  • National Health and Medical Research Council, Australian Government
  • National Health and Medical Research Council

Zitieren

APA

Patabendige, M., Chan, F., Vayssiere, C., Ehlinger, V., Van Gemund, N., le Cessie, S., Prager, M., Marions, L., Rozenberg, P., Chevret, S., Young, D. C., Le Roux, P. A., Gregson, S., Waterstone, M., Rolnik, D. L., Mol, B. W., & Li, W. (2024). Vaginal misoprostol versus vaginal dinoprostone for cervical ripening and induction of labour: An individual participant data meta‐analysis of randomised controlled trials. BJOG: An International Journal of Obstetrics & Gynaecology. https://doi.org/10.1111/1471-0528.17794

Vancouver

Patabendige M, Chan F, Vayssiere C, Ehlinger V, Van Gemund N, le Cessie S, et al. Vaginal misoprostol versus vaginal dinoprostone for cervical ripening and induction of labour: An individual participant data meta‐analysis of randomised controlled trials. BJOG: An International Journal of Obstetrics & Gynaecology. 2024. doi:10.1111/1471-0528.17794

BibTeX
@article{Patabendige2024,
  author = {Patabendige, Malitha and Chan, Fei and Vayssiere, Christophe and Ehlinger, Virginie and Van Gemund, Nicolette and le Cessie, Saskia and Prager, Martina and Marions, Lena and Rozenberg, Patrick and Chevret, Sylvie and Young, David C and Le Roux, Paul A and Gregson, Sarah and Waterstone, Mark and Rolnik, Daniel L and Mol, Ben W and Li, Wentao},
  title = {Vaginal misoprostol versus vaginal dinoprostone for cervical ripening and induction of labour: An individual participant data meta‐analysis of randomised controlled trials},
  journal = {BJOG: An International Journal of Obstetrics & Gynaecology},
  year = {2024},
  doi = {10.1111/1471-0528.17794}
}
Kostenlos starten →